RECORDATI
Recordati S.p.A., a prominent player in the pharmaceutical industry, is headquartered in Luxembourg (LU) and operates extensively across Europe, North America, and other global markets. Founded in 1926, Recordati has established itself as a leader in the development and marketing of innovative medicines, particularly in the fields of rare diseases and specialty pharmaceuticals. The company’s core offerings include a diverse range of prescription drugs, with a strong emphasis on treatments for rare diseases, urology, and cardiovascular conditions. Recordati's commitment to research and development sets it apart, enabling the introduction of unique therapies that address unmet medical needs. With a robust market position, Recordati has achieved significant milestones, including strategic acquisitions and partnerships that enhance its portfolio and global reach.
DitchCarbon Score
How does RECORDATI's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RECORDATI's score of 36 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RECORDATI's reported carbon emissions
In 2023, RECORDATI reported total carbon emissions of approximately 36,607,000 kg CO2e from Scope 1 and 15,660,000 kg CO2e from Scope 2, resulting in a combined total of about 38,173,000 kg CO2e. This marks a significant reduction from previous years, with emissions decreasing from approximately 37,768,000 kg CO2e in 2022 and 37,511,000 kg CO2e in 2021. The company has demonstrated a commitment to reducing its carbon footprint, achieving a notable decrease in emissions over the years. For instance, Scope 1 emissions have decreased from about 37,511,000 kg CO2e in 2021 to 36,607,000 kg CO2e in 2023. RECORDATI has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, indicating a potential area for future commitment. The company continues to focus on improving its sustainability practices as part of its operational strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 34,458,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 10,567,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RECORDATI is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
